Compare · SERM
Enclomiphene vs Tamoxifen
Both are serm compounds. Here's how they line up on the evidence — graded the same way.
| Enclomiphene | Tamoxifen | |
|---|---|---|
| Evidence | Preliminary human | Strong human |
| Class | SERM | SERM |
| Summary | Enclomiphene is the anti-estrogenic isomer of clomiphene — a selective estrogen receptor modulator (SERM), not a peptide. Human trials consistently show it raises testosterone while preserving fertility, but it is NOT FDA-approved for any use, is available only via off-label compounding, and is banned in sport at all times. | Tamoxifen is a selective estrogen receptor modulator (SERM) — an FDA-approved breast-cancer drug with one of the strongest evidence bases in oncology, not a peptide. Anabolic-steroid users take it off-label to blunt gynecomastia and attempt testosterone 'restart,' an unstudied practice that is banned in sport (WADA S4.2) and not without real risk. |
| Full profile → | Full profile → |
Enclomiphene
Enclomiphene gets passed around fitness and "research chemical" circles as if it were a peptide or a sleek next-generation drug. It is neither. It is one of the two isomers of clomiphene — the anti-estrogenic half — and it is a small-molecule oral selective estrogen receptor modulator (SERM) in the…
Tamoxifen
Tamoxifen, sold as Nolvadex, is a selective estrogen receptor modulator (SERM) and one of the most thoroughly studied drugs in all of oncology. It is important to be precise about what it is: tamoxifen is not a peptide, not an aromatase inhibitor (those, like anastrozole and exemestane, block…